Ignite Creation Date:
2025-12-24 @ 4:23 PM
Ignite Modification Date:
2025-12-28 @ 6:41 PM
Study NCT ID:
NCT01085266
Status:
TERMINATED
Last Update Posted:
2016-10-12
First Post:
2010-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease
Sponsor:
Medivation, Inc.
Organization: